Through deep learning, researchers at MIT have successfully discovered a new type of antibiotic that effectively combats drug-resistant bacteria, which cause more than 10,000 deaths annually. The application of artificial intelligence in the medical field is gaining increasing attention, and MIT's research provides an efficient and resource-effective framework for drug development. Researchers have shared their findings with the startup Phare Bio, planning further data analysis to search for compounds that can kill other bacteria. This study offers mechanical insights into the application of deep learning in antibiotic development and provides a new approach to addressing the problem of antibiotic resistance.